JP2016539131A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539131A5
JP2016539131A5 JP2016535210A JP2016535210A JP2016539131A5 JP 2016539131 A5 JP2016539131 A5 JP 2016539131A5 JP 2016535210 A JP2016535210 A JP 2016535210A JP 2016535210 A JP2016535210 A JP 2016535210A JP 2016539131 A5 JP2016539131 A5 JP 2016539131A5
Authority
JP
Japan
Prior art keywords
salt
arachidylamide
cholan
dihydroxy
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016535210A
Other languages
English (en)
Japanese (ja)
Other versions
JP6675310B2 (ja
JP2016539131A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2014/051052 external-priority patent/WO2015083164A1/en
Publication of JP2016539131A publication Critical patent/JP2016539131A/ja
Publication of JP2016539131A5 publication Critical patent/JP2016539131A5/ja
Application granted granted Critical
Publication of JP6675310B2 publication Critical patent/JP6675310B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016535210A 2013-12-04 2014-12-04 アラムコール塩 Active JP6675310B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361911478P 2013-12-04 2013-12-04
US61/911,478 2013-12-04
PCT/IL2014/051052 WO2015083164A1 (en) 2013-12-04 2014-12-04 Aramchol salts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020040825A Division JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Publications (3)

Publication Number Publication Date
JP2016539131A JP2016539131A (ja) 2016-12-15
JP2016539131A5 true JP2016539131A5 (enExample) 2018-01-18
JP6675310B2 JP6675310B2 (ja) 2020-04-01

Family

ID=53272986

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016535210A Active JP6675310B2 (ja) 2013-12-04 2014-12-04 アラムコール塩
JP2020040825A Pending JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020040825A Pending JP2020111584A (ja) 2013-12-04 2020-03-10 アラムコール塩

Country Status (21)

Country Link
US (1) US20160304553A1 (enExample)
EP (1) EP3077047B1 (enExample)
JP (2) JP6675310B2 (enExample)
KR (1) KR102320191B1 (enExample)
CN (2) CN110437298A (enExample)
AU (2) AU2014358668B2 (enExample)
BR (1) BR112016012465B1 (enExample)
CA (1) CA2930232C (enExample)
CY (1) CY1121736T1 (enExample)
DK (1) DK3077047T3 (enExample)
ES (1) ES2732845T3 (enExample)
HR (1) HRP20191023T1 (enExample)
HU (1) HUE045209T2 (enExample)
LT (1) LT3077047T (enExample)
PL (1) PL3077047T3 (enExample)
PT (1) PT3077047T (enExample)
RS (1) RS59067B1 (enExample)
SI (1) SI3077047T1 (enExample)
SM (1) SMT201900363T1 (enExample)
TR (1) TR201909447T4 (enExample)
WO (1) WO2015083164A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL227890A0 (en) * 2013-08-08 2014-01-30 Galderm Therapeutics Ltd Antiaging compounds containing bile acid and fatty acid conjugates
WO2016199137A1 (en) 2015-06-10 2016-12-15 Galmed Research And Development Ltd. Low dose compositions of aramchol salts
HUE045209T2 (hu) * 2013-12-04 2019-12-30 Galmed Res & Development Ltd Aramchol-sók
NZ739679A (en) * 2015-07-12 2022-02-25 Cfso Gmbh Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency
WO2017017677A1 (en) * 2015-07-27 2017-02-02 Galmed Research And Development Ltd. Combination treatment for liver disease
IL243707A0 (en) 2016-01-20 2016-05-01 Galmed Res And Dev Ltd Treatment to regulate the microbiota in the intestine
FR3050112B1 (fr) 2016-04-15 2020-09-04 Soc Civ Immobiliere Gecinq Utilisation de l'acide fenofibrique dans le traitement des maladies hepatiques
US10588880B2 (en) * 2016-09-28 2020-03-17 Eiger Biopharmaceuticals, Inc. Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis
MA46786A (fr) * 2016-11-10 2019-09-18 Galmed Res And Development Ltd Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcoolique
US11197870B2 (en) 2016-11-10 2021-12-14 Galmed Research And Development Ltd Treatment for hepatic fibrosis
WO2018223836A1 (zh) * 2017-06-07 2018-12-13 苏州科睿思制药有限公司 一种脂肪酸胆汁酸偶合物的晶型及其制备方法和用途
IL273078B2 (en) 2017-09-13 2025-06-01 Emmyon Inc Ursolic acid morpholine and diethanolamine salts
WO2019125913A1 (en) * 2017-12-20 2019-06-27 Michael Guarnieri Nutritional bolus for animals
JP6612004B1 (ja) * 2018-07-31 2019-11-27 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026471A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
KR20240032679A (ko) * 2022-09-02 2024-03-12 주식회사 렉스팜텍 신규 벤포티아민 콜린염
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2252863A (en) * 1941-02-03 1941-08-19 Searle & Co Quaternary ammonium salts
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes
US7098196B1 (en) * 1999-10-13 2006-08-29 Johns Hopkins University School Of Medicine Regulators of the hedgehog pathway, compositions and uses related thereto
US8975246B2 (en) * 2001-04-17 2015-03-10 Galmed Research And Development Ltd. Bile acid or bile salt fatty acid conjugates
EP1742631A4 (en) * 2004-04-28 2009-11-11 Merck & Co Inc FLUORATED 4-AZASTEROIDS AS ANDROGEN RECEPTOR MODULATORS
ITMI20061735A1 (it) * 2006-09-12 2008-03-13 Dipharma Spa Procedimento per la preparazione di acidi colanici
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
WO2010086864A1 (en) * 2009-02-02 2010-08-05 Galmed International Ltd. Methods and compositions for treating alzheimer's disease
CN102656181A (zh) * 2009-12-15 2012-09-05 明治制果药业株式会社 三萜衍生物及用于预防或治疗c型慢性肝炎的药剂
CN102115486B (zh) * 2009-12-30 2015-06-03 上海特化医药科技有限公司 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法
BR112012018913A2 (pt) * 2010-01-28 2017-06-20 Merck Sharp & Dohme "composição farmacêutica, e, uso da composição"
PT2531501E (pt) * 2010-02-03 2014-02-17 Takeda Pharmaceutical Inibidores da cinase de regulação do sinal de apoptose 1
HRP20180970T1 (hr) * 2010-12-07 2018-08-10 Amira Pharmaceuticals, Inc. Policiklični lpa1 antagonist i njegove primjene
HUE045209T2 (hu) * 2013-12-04 2019-12-30 Galmed Res & Development Ltd Aramchol-sók

Similar Documents

Publication Publication Date Title
JP2016539131A5 (enExample)
HRP20191023T1 (hr) Soli aramchola
JP2014501282A5 (enExample)
JP2020519654A5 (enExample)
JP2012521994A5 (enExample)
JP2013516473A5 (enExample)
RU2577334C2 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА МОНОГИДРАТА ГИДРОХЛОРИДА (R)-7-ХЛОР-N-(ХИНУКЛИДИН-3-ИЛ)БЕНЗО[b]ТИОФЕН-2-КАРБОКСАМИДА
JP2013541592A5 (enExample)
CN108794481A (zh) 化合物的多晶型、其制备方法和用途
JP2017533895A5 (enExample)
TWI721947B (zh) 抗病毒化合物的固態形式
JP2018507886A5 (enExample)
JP2010519300A5 (enExample)
JP2023083528A5 (enExample)
JP2023103328A (ja) ビランテロールトリフェニル酢酸塩の新規な結晶形態及びこれらの調製プロセス
CN102149671A (zh) 甲磺酸雷沙吉兰的多晶形式
JP2017519015A5 (enExample)
CN101595099B (zh) 晶体盐酸度洛西汀
JP6166721B2 (ja) 4−tert−ブチル−N−[4−クロロ−2−(1−オキシ−ピリジン−4−カルボニル)−フェニル]−ベンゼンスルホンアミドのナトリウム塩の多形
JP2020518571A5 (enExample)
JP2017132781A5 (enExample)
JP6122002B2 (ja) 4−tert−ブチル−N−[4−クロロ−2−(1−オキシ−ピリジン−4−カルボニル)−フェニル]−ベンゼンスルホンアミドのナトリウム塩の多形
JP2018516946A5 (enExample)
CN103443084A (zh) 制备苯达莫司汀的方法
TW201217346A (en) Process for preparing the crystalline form II of febuxostat